LncRNA BANCR Promotes Tumorigenesis and Enhances Adriamycin Resistance in Colorectal Cancer

Overview

Journal Aging (Albany NY)

Specialty Geriatrics

Date 2018 Aug 26

PMID 30144787

Citations 38

Authors

Siping Ma

Dongxiang Yang

Yanlong Liu

Yongpeng Wang

Tao Lin

Yanxi Li

Shihua Yang

Wanchuan Zhang

Rui Zhang

Affiliations

Soon will be listed here.

Abstract

Colorectal cancer (CRC) is the third most common malignancy in the United States. Chemotherapeutic resistance is a massive obstacle for cancer treatment. The roles and molecular basis of long non-coding RNA BRAF-activated noncoding RNA (BANCR) in CRC progression and adriamycin (ADR) resistance have not been extensively identified. In this study, we found that BANCR and CSE1L expressions were upregulated in CRC tumor tissues. Meanwhile, CSE1L expression was correlated with depth of CRC. BANCR silencing suppressed cell proliferation and invasion capacity, increased apoptotic rate and potentiated cell sensitivity to ADR. CSE1L downregulation triggered a reduction of cell proliferation and invasion ability, and an increase of apoptosis rate and cell sensitivity to ADR. CSE1L overexpression attenuated si-BANCR-mediated anti-proliferation, anti-invasion and pro-apoptosis effects in CRC cells. BANCR acted as a molecular sponge of miR-203 to sequester miR-203 away from CSE1L in CRC cells, resulting in the upregulation of CSE1L expression. CSE1L knockdown inhibited expressions of DNA-repair-related proteins (53BP1 and FEN1) in HCT116 cells. BANCR knockdown also inhibited tumor growth and enhanced ADR sensitivity in CRC mice model. In conclusion, BANCR knockdown suppressed CRC progression and strengthened chemosensitization of CRC cells to ADR possibly by regulating miR-203/CSE1L axis, indicating that BANCR might be a promising target for CRC treatment.

Citing Articles

Crosstalk between non-coding RNAs and programmed cell death in colorectal cancer: implications for targeted therapy.

Taha S, Karimi M, Mahdavi B, Yousefi Tehrani M, Bemani A, Kabirian S Epigenetics Chromatin. 2025; 18(1):3.

PMID: 39810224 PMC: 11734566. DOI: 10.1186/s13072-024-00560-8.

Analysis of exportins expression unveils their prognostic significance in colon adenocarcinoma: insights from public databases.

Kalia P, Nair R, Yadav S Discov Oncol. 2025; 16(1):21.

PMID: 39776001 PMC: 11711428. DOI: 10.1007/s12672-025-01748-4.

TRIP13 Activates Glycolysis to Promote Cell Stemness and Strengthen Doxorubicin Resistance of Colorectal Cancer Cells.

Liu G, Wang H, Ran R, Wang Y, Li Y Curr Med Chem. 2024; 31(22):3397-3411.

PMID: 38347785 DOI: 10.2174/0109298673255498231117100421.

BRAFV600E, BANCR, miR-203a-3p and miR-204-3p in Risk Stratification of PTC Patients.

Stojanovic S, Selemetjev S, doric I, Miljus J, Tatic S, Zivaljevic V Biomedicines. 2023; 11(12).

PMID: 38137560 PMC: 10742276. DOI: 10.3390/biomedicines11123338.

Fasting regulates mitochondrial function through lncRNA PRKCQ-AS1-mediated IGF2BPs in papillary thyroid carcinoma.

Zhang X, Zhong Y, Liu L, Jia C, Cai H, Yang J Cell Death Dis. 2023; 14(12):827.

PMID: 38092752 PMC: 10719255. DOI: 10.1038/s41419-023-06348-0.

References

Cunningham D, Atkin W, Lenz H, Lynch H, Minsky B, Nordlinger B . Colorectal cancer. Lancet. 2010; 375(9719):1030-47. DOI: 10.1016/S0140-6736(10)60353-4. View

Hur K, Toiyama Y, Okugawa Y, Ide S, Imaoka H, Boland C . Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer. Gut. 2015; 66(4):654-665. PMC: 4919275. DOI: 10.1136/gutjnl-2014-308737. View

Giunta S, Belotserkovskaya R, Jackson S . DNA damage signaling in response to double-strand breaks during mitosis. J Cell Biol. 2010; 190(2):197-207. PMC: 2930281. DOI: 10.1083/jcb.200911156. View

Pimiento J, Neill K, Henderson-Jackson E, Eschrich S, Chen D, Husain K . Knockdown of CSE1L Gene in Colorectal Cancer Reduces Tumorigenesis in Vitro. Am J Pathol. 2016; 186(10):2761-8. PMC: 5222983. DOI: 10.1016/j.ajpath.2016.06.016. View

Siegel R, Miller K, Fedewa S, Ahnen D, Meester R, Barzi A . Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017; 67(3):177-193. DOI: 10.3322/caac.21395. View

Yu X, Zheng H, Chan M, Wu W . BANCR: a cancer-related long non-coding RNA. Am J Cancer Res. 2017; 7(9):1779-1787. PMC: 5622215. View

Chin S, Wu P, Shih Y, Yeh C, Lee W, Shen S . High expression of cytoplasmic phosphorylated CSE1L in malignant melanoma but not in benign nevi: phosphorylated CSE1L for the discrimination between melanoma and benign nevi. Int J Clin Exp Pathol. 2015; 8(2):1393-401. PMC: 4396273. View

Li J, Chen Y, Zhao J, Kong F, Zhang Y . miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression. Cancer Lett. 2011; 304(1):52-9. DOI: 10.1016/j.canlet.2011.02.003. View

Tai C, Su T, Jiang M, Chen H, Shen S, Lee W . Correlations between cytoplasmic CSE1L in neoplastic colorectal glands and depth of tumor penetration and cancer stage. J Transl Med. 2013; 11:29. PMC: 3564816. DOI: 10.1186/1479-5876-11-29. View

10.

Alnabulsi A, Agouni A, Mitra S, Garcia-Murillas I, Carpenter B, Bird S . Cellular apoptosis susceptibility (chromosome segregation 1-like, CSE1L) gene is a key regulator of apoptosis, migration and invasion in colorectal cancer. J Pathol. 2012; 228(4):471-81. DOI: 10.1002/path.4031. View

11.

Guo Q, Zhao Y, Chen J, Hu J, Wang S, Zhang D . BRAF-activated long non-coding RNA contributes to colorectal cancer migration by inducing epithelial-mesenchymal transition. Oncol Lett. 2014; 8(2):869-875. PMC: 4081361. DOI: 10.3892/ol.2014.2154. View

12.

Tian L, Li M, Ge J, Guo Y, Sun Y, Liu M . MiR-203 is downregulated in laryngeal squamous cell carcinoma and can suppress proliferation and induce apoptosis of tumours. Tumour Biol. 2014; 35(6):5953-63. DOI: 10.1007/s13277-014-1790-7. View

13.

Lee J, Kang Y, Khare V, Jin Z, Kang M, Yoon Y . The p53-inducible gene 3 (PIG3) contributes to early cellular response to DNA damage. Oncogene. 2009; 29(10):1431-50. DOI: 10.1038/onc.2009.438. View

14.

Paraskevopoulou M, Hatzigeorgiou A . Analyzing MiRNA-LncRNA Interactions. Methods Mol Biol. 2016; 1402:271-286. DOI: 10.1007/978-1-4939-3378-5_21. View

15.

Pritchard C, Grady W . Colorectal cancer molecular biology moves into clinical practice. Gut. 2010; 60(1):116-29. PMC: 3006043. DOI: 10.1136/gut.2009.206250. View

16.

Li T, Gao F, Zhang X . miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer. Oncol Rep. 2014; 33(2):607-14. DOI: 10.3892/or.2014.3646. View

17.

Li R, Zhang L, Jia L, Duan Y, Li Y, Bao L . Long non-coding RNA BANCR promotes proliferation in malignant melanoma by regulating MAPK pathway activation. PLoS One. 2014; 9(6):e100893. PMC: 4072697. DOI: 10.1371/journal.pone.0100893. View

18.

Han D, Wang M, Ma N, Xu Y, Jiang Y, Gao X . Long noncoding RNAs: novel players in colorectal cancer. Cancer Lett. 2015; 361(1):13-21. DOI: 10.1016/j.canlet.2015.03.002. View

19.

Ayers D, Vandesompele J . Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance. Genes (Basel). 2017; 8(3). PMC: 5368699. DOI: 10.3390/genes8030095. View

20.

Chen Q, Wei C, Wang Z, Sun M . Long non-coding RNAs in anti-cancer drug resistance. Oncotarget. 2016; 8(1):1925-1936. PMC: 5352108. DOI: 10.18632/oncotarget.12461. View